Latest News
AMD Slips 6.5% Despite Goldman Upgrade as AI Hopes Face Scrutiny
AMD shares tumbled 6.51% to $516.11 despite a Goldman Sachs target hike, as the broader chip sector slumped and AI optimism meets demand for tangible results.
South Korean Stocks Tumble 20% from Peak Amid Chipmaker Volatility and AI Jitters
South Korean shares dropped 20% from their peak amid chipmaker volatility and AI concerns. Crinetics Pharmaceuticals surged 98.7% on a $10 billion Vertex acquisition deal.
Vera Therapeutics Gains as FDA Nod for Trutakna Puts Focus on Q3 Kidney Data
Vera Therapeutics (NASDAQ:VERA) shares climbed 7% following FDA accelerated approval of Trutakna for IgA nephropathy. The next key catalyst is Q3 2026 eGFR data from the ORIGIN 3 trial.
Sky Quarry Shares Surge on Restart Hopes, Trading Volume Exceeds Market Cap
Shares of Sky Quarry jumped 26.9% to $2.69, with trading volume of 21.3 million shares, or $57.2 million, over 4.5 times its $12.8 million market cap, driven by the company's Nevada refinery restart plan.
Bandwidth Soars 12% as Convertible Note Conversion Nears
Bandwidth shares surged 12.2% to $68.09, now trading just 6.7% below the $72.64 conversion price for its zero-coupon convertible notes due 2032. The move comes ahead of Q2 earnings on July 29.
Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug
Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.
